Serum ferritin levels in hematologic malignant neoplasms

Area of Science:

• Hematology
• Oncology
• Biochemistry

Background:

• Serum ferritin is an iron-storage protein.
• Elevated ferritin levels can indicate inflammation or malignancy.
• The role of serum ferritin in hematologic neoplasms requires further elucidation.

Purpose of the Study:

• To investigate the relationship between serum ferritin levels and clinical status in patients with hematologic malignant neoplasms.
• To assess the potential diagnostic and prognostic value of serum ferritin in these conditions.

Main Methods:

• Analysis of serum ferritin concentrations in 90 patients diagnosed with various hematologic malignant neoplasms.
• Correlation of ferritin levels with clinical status and specific diagnoses.

Main Results:

• Significantly elevated serum ferritin levels were observed in patients with Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, blastic crisis of chronic myelocytic leukemia, acute myeloblastic leukemia, and acute lymphoblastic leukemia.
• These findings indicate a strong association between high serum ferritin and specific hematologic cancers.

Conclusions:

• Serum ferritin concentration is significantly elevated in a range of hematologic malignant neoplasms.
• Serum ferritin determination may serve as a valuable biomarker for the diagnosis and follow-up of patients with these cancers.